Reserve Dairy Names for Animal Milk Products

Summary#

This bill would change how the Food and Drug Administration (FDA) polices the use of dairy terms like “milk,” “cheese,” and “yogurt” on food labels. It adds a new rule that a product cannot use a standardized dairy name unless it is made from the lacteal secretion of hooved mammals (animal milk) or it meets FDA’s rules for “imitation” foods. The broad goal is to stop non-dairy products from using dairy names.

Key changes:

• Defines “dairy product” as food that is, contains as a primary ingredient, or is derived from animal milk from hooved mammals.
• Says a food is misbranded if it uses a standardized dairy term but is not a dairy product and does not meet FDA’s imitation labeling rules.
• Points to existing FDA standards of identity for dairy terms (in 21 CFR parts 131, 133, and certain 135 sections) as the protected names.
• Orders FDA to issue draft enforcement guidance within 90 days and final guidance within 180 days.
• Voids any existing FDA guidance that conflicts with this new rule.
• Requires FDA to report to Congress within 2 years on warnings and penalties issued and to provide an updated enforcement plan if misbranded products are still on the market.

What it means for you#

• Food and beverage companies (plant-based or other non-dairy):

  • Products using names like those defined in FDA’s dairy standards (for example, “milk,” “cheese,” “yogurt,” and related standardized terms) would likely need to stop using those names unless the product is made from animal milk or is labeled to meet FDA’s imitation rules.
  • You may need to change labels, marketing, and possibly product names to avoid using standardized dairy terms, unless your product qualifies under the imitation provision.
  • You should expect FDA enforcement in line with the forthcoming guidance.

• Dairy producers:

  • The bill would direct FDA to limit dairy-standard names to animal-milk products, which could reduce use of those names by non-dairy competitors.

• Retailers:

  • You may need to ensure products on shelves use compliant labels once FDA begins enforcing the rule. Non-compliant items could face warnings or other penalties, which may affect inventory.

• Consumers:

  • Product names and labels for non-dairy alternatives could change. This may affect how you find or recognize certain products on shelves.

• FDA and regulators:

  • Must create and carry out an enforcement plan on the new misbranding rule, replace conflicting guidance, and report enforcement activity to Congress within 2 years.

• Timing:

  • Draft guidance within 90 days of enactment; final guidance within 180 days. The bill does not set a separate grace period for relabeling.

• What is unclear:

  • The bill does not define “primary ingredient” further.
  • It does not list specific terms beyond referencing FDA’s dairy standards by citation.
  • It does not state how quickly enforcement will proceed after guidance or how existing inventory will be handled.

Expenses#

The bill may increase administrative and enforcement costs for FDA, and may create compliance costs for businesses, but no estimate is available.

• FDA would need staff time to draft guidance, enforce the rule, and prepare the 2-year report to Congress.
• Companies that change labels or product names could face design, printing, and marketing costs, and potential product placement changes at retail.
• Retailers may incur modest compliance and inventory management costs tied to relabeled products.
• No publicly available information on total costs or savings.

Proponents' View#

• The bill appears intended to enforce long-standing FDA standards of identity for dairy products and ensure that only animal-milk products use standardized dairy names.
• Supporters may argue this improves label clarity and reduces consumer confusion about whether a product is dairy or non-dairy.
• It could be seen as promoting fairness by reserving standardized dairy terms for products that meet the defined dairy criteria.
• The timelines for guidance and the reporting requirement could improve accountability and consistent enforcement.

Opponents' View#

• One concern is that the bill may require many well-known non-dairy products to change names or labels, creating costs and potential confusion during the transition.
• It is unclear how “primary ingredient” will be interpreted, which could create uncertainty for compliance.
• Businesses may face significant relabeling and marketing expenses, especially if enforcement begins quickly after guidance is final.
• FDA enforcement resources are limited; directing them to label policing may divert attention from other food safety priorities.
• If products must use “imitation” labeling to stay on shelves, some may argue this does not reflect consumer understanding of these products’ identity and could affect market competition.